Dow Down 0.18% Nasdaq Up 0.39%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.40 Down 0.02(1.41%) 4:00PM EDT
|After Hours : 1.39 Down 0.01 (0.71%) 5:56PM EDT
Prev Close:1.42
Open:1.43
Bid:N/A
Ask:1.72 x 2000
1y Target Est:4.50
Beta:3.76
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.39 - 1.45
52wk Range:1.10 - 2.14
Volume:1,038,815
Avg Vol (3m):1,775,310
Market Cap:368.03M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXDown 1.41%368.03M
GSKDown 1.65%115.99B
MRKDown 0.53%172.47B
RHHBYUp 0.14%248.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback